New company plans progestin-only ECP.
D000569:Americas; D003257:Consumer Product Safety; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003281:Contraceptives, Postcoital; D019049:Developed Countries; D005193:Family Planning Services; D007878:Legislation as Topic; D016912:Levonorgestrel; D009656:North America; D014481:United States
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003281:Contraceptives, Postcoital; D016912:Levonorgestrel
Americas; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Postcoital; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents--administraction and dosage; Developed Countries; Family Planning; Fertility Control, Postcoital; Legislation; Levonorgestrel--administraction and dosage; North America; Northern America; Product Approval; United States